Lumonus tops up Series B to $28m, US expansion means sales hiring
Sydney medtech Lumonus added $3m to its Series B four months after the initial close, bringing total raise to $28m. The funds are going straight into US go-to-market and clinical success teams. Translation: they are hiring sales roles to scale their AI-powered cancer treatment platform across US health systems.